Atricure Inc (ATRC)

Apr 18, 2025

Cryoablation Market Set to Witness Significant Growth by 2032 | - openPR.com

Apr 18, 2025

Apr 11, 2025

AtriCure Announces First Use of the AtriClip PRO-Mini® Device | - GuruFocus

Apr 11, 2025

Apr 10, 2025

AtriCure launches smaller device for heart surgery By Investing.com - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

AtriCure announces first use of newest AtriClip device - MassDevice

Apr 10, 2025

Apr 10, 2025

AtriCure Reports 1st Use of Newest AtriClip LAA Exclusion System - Medical Product Outsourcing

Apr 10, 2025

Apr 10, 2025

AtriCure launches smaller device for heart surgery - Investing.com Australia

Apr 10, 2025

Apr 10, 2025

AtriCure Announces First Use of the AtriClip PRO-Mini® Device - Yahoo Finance

Apr 10, 2025

Apr 08, 2025

Dayton’s stocks continue loss streak following election and now tariffs - The Business Journals

Apr 08, 2025

Apr 08, 2025

AtriCure Drops 25%: Bargain Or Caution Sign? (NASDAQ:ATRC) - Seeking Alpha

Apr 08, 2025

Apr 08, 2025

AtriCure to Announce First Quarter 2025 Financial Results - MarketScreener

Apr 08, 2025

Apr 04, 2025

Is AtriCure (NASDAQ:ATRC) A Risky Investment? - simplywall.st

Apr 04, 2025

Apr 02, 2025

JMP maintains AtriCure stock with $60 target post-Investor Day By Investing.com - Investing.com Canada

Apr 02, 2025

Mar 29, 2025

When the Price of (ATRC) Talks, People Listen - news.stocktradersdaily.com

Mar 29, 2025

Mar 28, 2025

Canaccord Genuity Adjusts Price Target on AtriCure to $52 From $66, Maintains Buy Rating - MarketScreener

Mar 28, 2025

Mar 27, 2025

Oppenheimer maintains AtriCure stock Outperform rating, $45 target By Investing.com - Investing.com Australia

Mar 27, 2025

Mar 27, 2025

UBS maintains Buy on AtriCure stock, reiterates $60 target By Investing.com - Investing.com Australia

Mar 27, 2025

Mar 27, 2025

UBS maintains Buy on AtriCure stock, reiterates $60 target - Investing.com

Mar 27, 2025

Mar 27, 2025

Piper Sandler maintains $50 target on AtriCure stock, cites growth By Investing.com - Investing.com Canada

Mar 27, 2025

Mar 27, 2025

Piper Sandler maintains $50 target on AtriCure stock, cites growth - Investing.com

Mar 27, 2025

Mar 27, 2025

Needham maintains Buy on AtriCure stock, $51 target By Investing.com - Investing.com Australia

Mar 27, 2025

Mar 27, 2025

Needham maintains Buy on AtriCure stock, $51 target - Investing.com

Mar 27, 2025

Mar 27, 2025

Oppenheimer maintains AtriCure stock Outperform rating, $45 target - Investing.com

Mar 27, 2025

Mar 27, 2025

BTIG raises AtriCure stock price target to $58, maintains buy By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

BTIG raises AtriCure stock price target to $58, maintains buy - Investing.com

Mar 27, 2025

Mar 26, 2025

AtriCure Highlights Growth and Innovation at Investor Day - TipRanks

Mar 26, 2025

Mar 26, 2025

Electrophysiology Devices Market Poised for Strong Growth, Projected to Expand at a 9.73% CAGR by 2030, Reports DelveInsight - Barchart.com

Mar 26, 2025

Mar 22, 2025

Needham maintains AtriCure stock Buy rating, $51 target By Investing.com - Investing.com Canada

Mar 22, 2025

Mar 21, 2025

11 Analysts Have This To Say About AtriCure - Benzinga

Mar 21, 2025

Mar 21, 2025

Needham maintains AtriCure stock Buy rating, $51 target - Investing.com India

Mar 21, 2025

Mar 19, 2025

(ATRC) Investment Analysis - news.stocktradersdaily.com

Mar 19, 2025

Mar 12, 2025

AtriCure to Host Analyst & Investor Day on March 26, 2025 - Yahoo Finance

Mar 12, 2025

Mar 12, 2025

AtriCure Investor Day: New Product Pipeline and Financial Targets Coming March 2025 - Stock Titan

Mar 12, 2025

Mar 09, 2025

AtriCure, Inc. to Host Earnings Call - ACCESS Newswire

Mar 09, 2025

Mar 09, 2025

AtriCure Independent Director Karen Prange Sells 25% Of Holding - Simply Wall St

Mar 09, 2025

Mar 08, 2025

(ATRC) Long Term Investment Analysis - Stock Traders Daily

Mar 08, 2025

Mar 08, 2025

AtriCure (NASDAQ:ATRC) Stock Price Down 6% Following Insider Selling - Defense World

Mar 08, 2025

Mar 08, 2025

Atricure director Karen Prange sells $232,531 in stock By Investing.com - Investing.com Canada

Mar 08, 2025